Novedades en inmunoterapia: lupus, migraña, autoinmunidad, cáncer

– Teclistamab-Induced Remission in Refractory Systemic Lupus Erythematosus. N Engl J Med 2024;391:864-866.
– BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease. N Engl J Med 2024;391:867-869.
– A Monoclonal Antibody to PACAP for Migraine Prevention. N Engl J Med 2024;391:800-809.
– A New Antibody Treatment for Migraine. N Engl J Med 2024;391:855-857.
– Generation of dual-attribute iTNK cells from hPSCs for cancer immunotherapy. Cell Reports Methods, 2024;4(9).
– Agonist antibody to guanylate cyclase receptor NPR1 regulates vascular tone. Nature, 2024;633:654–661.